Trial intelligence / Profile preview

CALR Allele Burden in CALR Mutated Myeloproliferative Syndromes

NCT04942080Recruiting

Sponsor
Centre Hospitalier Universitaire d'Angers
Start
Oct 2021
Primary completion
Apr 2027
Countries
1
01

Overview

Single-arm trial, sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Time to onset of disease progression at 3 years. Started Oct 2021; status: recruiting.

Beyond the preview

Go deeper on NCT04942080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04942080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call